Voyager Therapeutics, Inc.
VYGR · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $71 | $69 | $99 | $117 |
| Short-Term Investments | $195 | $162 | $20 | $15 |
| Receivables | $4 | $84 | $1 | $1 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $6 | $4 | $5 | $3 |
| Total Curr. Assets | $277 | $320 | $124 | $137 |
| Property Plant & Equip (Net) | $48 | $30 | $33 | $55 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $66 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $3 | $2 | $2 | $2 |
| Total NC Assets | $116 | $32 | $35 | $57 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $393 | $351 | $159 | $194 |
| Liabilities | – | – | – | – |
| Payables | $4 | $2 | $3 | $1 |
| Short-Term Debt | $7 | $3 | $3 | $6 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $24 | $43 | $59 | $34 |
| Other Curr. Liab. | $14 | $17 | $8 | $11 |
| Total Curr. Liab. | $50 | $65 | $73 | $51 |
| LT Debt | $36 | $17 | $20 | $39 |
| Deferred Rev, NC | $6 | $32 | $6 | $8 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $1 | $1 | $1 | $1 |
| Total NC Liab. | $44 | $50 | $28 | $48 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $44 | $20 | $23 | $44 |
| Total Liabilities | $93 | $115 | $100 | $99 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$326 | -$261 | -$394 | -$347 |
| AOCI | -$0 | -$0 | -$0 | -$0 |
| Other Equity | $626 | $498 | $453 | $442 |
| Total Equity | $300 | $236 | $59 | $95 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $393 | $351 | $159 | $194 |
| Net Debt | -$28 | -$49 | -$76 | -$73 |